Keywords: study, supports, palonosetron, delayed, phase, cinv, action

Study supports palonosetron's delayed phase CINV action

Article | 22 September 2008

Print This

New data presented at the 33rd European Society of Medical Oncology Congress in Stockholm, Sweden, may contribute to explaining why ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in